维普中文期刊产品整合服务
31篇 您的检索式:作者名="HAYGLASS KT"
    题名 作者 年代 出处 被引量
1T cell chemokine receptor expression in human Thl-and Th2-associated diseases显示文摘Campbell JD HayGlass KT 2000Arch Immunol Ther Exp(Warsz)2000,48,6:1
2Endogenous IFN-gamma and IL-18 production directly limit induction of type 2 immunity in vivo显示文摘Lewkowich IP HayGlass KT 2002Eur J Immunol2002,32,12:1
3T cell chemkine receptor expression in human Th1 -and Th2 -associated diseases 显示文摘Campbell JD Hayglass KT 2000Arch Immunol Ther Exp (Warsz)2000,48,48:1
4Improved mRNA quantitation in LightCycler RT-PCR 显示文摘Ball TB Plummer FA HayGlass KT 2003Int Arch Allergy Immunol2003,130,1:1
5Endogenous IFN-gamma and IL-18 production directly Limit induction of type 2 immunity in vivo显示文摘Lewkowich IP HayGlass KT 2002Eur J Immunol2002,32,12:1
6In vivo IgE levels in exogenous antigen stimulated responses: measurement of total IgE as a valid, simple surrogate for Ag-specific IgE 显示文摘Lewkowich IP Rempel JD HayGlass KT 2004J Immunol Methods2004,286,12:1
7Improved mRNA Quantitation in LightCycler RT-PCR显示文摘Ball TB Plummer FA Hayglass KT 2003Int Arch Allergy Immunol2003,130,1:1
8Novel recombinant in- terleukin-13 peptide-based vaccine reduces airway allergic infla-mmatory responses in mice 显示文摘Ma Y HayGlass KT Becker AB et ol 2007Am J Respir Crit Care Med2007,176,5:1
9Novel cytokine peptide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice显示文摘Mal Y Hayglass KT Becker B 2007Allerg2007,62,6:1
10Endogenous IFN gnunaanad IL- 18 porduetion direeliy limitin of type 2 immuniytinvivo显示文摘Lewkowieh IP Hayglass KT 2002Eur JImmunol2002,32,12:1
11Acute Kidney Injury in Patients Undergoing Open Abdominal Aortic Aneurysm Repair:A Pilot Observational Trial显示文摘BRINKMAN R HAYGLASS KT MUTCH WA 2015J Cardiothorac Vasc Anesth2015,29,5:1
12Lower cortisol levels in children with asthma exposed to recurrent maternal distress from birth显示文摘Dreger LC Kozyrskyj AL HayGlass KT Becker AB MacNeil BJ 0,,:1
13Endogenous IFN-gamma and IL-18 production directly limit induction of type2 immunity in vivo显示文摘Lewkowich LP HayGlass KT 2002Eur J Immunol2002,32,12:1
14Novel recombinant inter- leukin-13 peptide-based vaccine reduces airway allergic inflammato- ry responses in mice 显示文摘Ma Y HayGlass KT Becker AB 2007Am J Respir Crit Care Med2007,176,5:1
15Novel cytokine pep- tide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice 显示文摘Ma Y Hayglass KT Becker AB et ol 2007Allergy2007,62,6:1
16Endogenous IFN - gamma an IL - 18 produetion directly limit induction of type 2 immunity in vivo 显示文摘Lewkowieh IP HayGlass KT 2002Eur J hnmunol2002,32,12:1
17Improved mRNA quantitation in Light Cycler RT-PCR 显示文摘Ball TB Plummer FA Hayglass KT 2003Int Arch Allergy Immunol2003,130,1:1
18T cell chemokine receptor expression in human Th 1-and Th2-associated diseases显示文摘CAMPBELL JD HAYGLASS KT 2000Arch Immunol Ther Exp (Warsz)2000,48,6:1
19T cell chemokine receptor expression in human Th1 and Th2 associated diseases显示文摘Campbell JD HayGlass KT 2000Arch Immunol Ther Exp (Warsz)2000,48,6:1
20Endogenous IFN-gamma and IL-18 production directly limit induction of type 2 immunity in vivo 显示文摘Lewkowich IP HayGlass KT 2002Eur J Immunol2002,32,12:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费